SAB Biotherapeutics, Inc.

Biotechnology company · Miami Beach, Florida, United States · Nasdaq: SABS

SAB Biotherapeutics, Inc. is a biotechnology company headquartered in Miami Beach, Florida, United States. Its earliest recorded incorporation is in 2020. Its shares trade on Nasdaq under the ticker SABS. The US FDA lists 2 drug manufacturing or testing sites registered to the company. It has received 3 US government small-business research awards (SBIR/STTR) from health agencies, $3 million in total, most recently in 2019. It has reported private securities offerings to the US SEC, most recently $175 million sold in a notice filed in 2025.

www.sabbiotherapeutics.comProfile compiled from public records. Is this your company? Request a correction or update

SAB Biotherapeutics at a glance

Typebiotechnology company
HeadquartersMiami Beach, Florida, United States
Earliest incorporation on record2020
Stock listingNasdaq: SABS
SEC industryBiological Products, (No Diagnostic Substances)
FDA-registered sites2
Employees (per SBIR records)45
SEC CIK1833214

What does SAB Biotherapeutics do?

Operations at its FDA-registered drug sites

API manufacturingAnalysisManufacturing

US government research funding

3 SBIR/STTR small-business research awards from US health agencies, $3 million in total (2016 to 2019). NIH funding came from the National Institute of Allergy and Infectious Diseases.

Private fundraising reported to the SEC

2 Form D notices; the most recent reported $175 million sold (2025).

Where is SAB Biotherapeutics located?

Headquarters: Miami Beach, Florida, United States

  • Canton, South DakotaSAB Biotherapeutics Pharm · FDA drug site
  • Sioux Falls, South DakotaSAB Biotherapeutics, Inc. · FDA drug site

Frequently asked questions about SAB Biotherapeutics

Where is SAB Biotherapeutics headquartered?

SAB Biotherapeutics, Inc. is headquartered in Miami Beach, Florida, United States.

What does SAB Biotherapeutics do?

SAB Biotherapeutics, Inc. is a biotechnology company. Its FDA-registered drug sites are registered for API manufacturing, analysis and manufacturing. Its SEC industry classification is Biological Products, (No Diagnostic Substances).

Is SAB Biotherapeutics a public company?

Yes. SAB Biotherapeutics, Inc. trades on Nasdaq under the ticker SABS.

When was SAB Biotherapeutics founded?

The earliest incorporation on record for SAB Biotherapeutics, Inc. is in 2020, according to public company registers.

How many FDA-registered sites does SAB Biotherapeutics have?

The US FDA lists 2 registered sites for SAB Biotherapeutics, Inc..

Similar companies

Need a CRO or CDMO for your next study?

Compare transparent quotes from research and manufacturing partners, then contract once. Free for buyers.

Compare quotes

Sources

Location data: GeoNames (geonames.org), CC BY 4.0.

Last updated 2026-09-23.